Skip to content

First in Human Study of TOS-358 in Adults with Soid Tumors

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-505346-26-01
Acronym
TOS-358-001
Enrollment
100
Registered
2024-01-10
Start date
2024-02-19
Completion date
Unknown
Last updated
2025-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

9 main solid tumors – colorectal, breast, cervical, endometrial, gastric, head and neck, ovarian and non-small cell lung cancers., urothelial

Interventions

None listed

Sponsors

Totus Medicines Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026